Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Gland Papillary Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01083550
What this trial is testing

Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer
University Health Network, Toronto 74
Not applicableLooking for participantsNCT06623578
What this trial is testing

Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC

Who this might be right for
Papillary Thyroid CarcinomaLymphatic Metastasis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 876
Not applicableStudy completedNCT01659385
What this trial is testing

Leptin Levels in Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer, PapillaryLeptin Levels
University of Nebraska 18
Testing effectiveness (Phase 2)Ended earlyNCT02408887
What this trial is testing

Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer

Who this might be right for
Low-risk Papillary Thyroid CancerEndocrine MalignancyThyroid Cancer
National Cancer Institute (NCI) 14
Not applicableEnded earlyNCT00416949
What this trial is testing

Iodine I 131 in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT01208051
What this trial is testing

Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer

Who this might be right for
Refractory Differentiated Thyroid Gland CarcinomaRefractory Thyroid Gland Follicular CarcinomaRefractory Thyroid Gland Hurthle Cell Carcinoma+2 more
National Cancer Institute (NCI) 127
Not applicableActive Not RecruitingNCT04948437
What this trial is testing

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

Who this might be right for
Thyroid CancerPapillary Thyroid CancerFollicular Thyroid Cancer
National Taiwan University Hospital 103
Not applicableLooking for participantsNCT00001160
What this trial is testing

Studies on Tumors of the Thyroid

Who this might be right for
Hurthle Cell Thyroid CancerTall Cell Variant Thyroid CancerFollicular Thyroid Cancer+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2,500
Large-scale testing (Phase 3)Looking for participantsNCT06082180
What this trial is testing

A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer

Who this might be right for
Thyroid CancerRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 1,199
Not applicableStudy completedNCT07652450
What this trial is testing

Incidental Thyroid Cancer in Cases With Inflammatory Thyroid Lesion

Who this might be right for
Papillary Thyroid CancerHashimoto DiseaseHashimoto's Thyroiditis+1 more
Minia University 98
Not applicableActive Not RecruitingNCT03271892
What this trial is testing

Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer Stage I
University Health Network, Toronto 200
Not applicableLooking for participantsNCT07357571
What this trial is testing

Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound

Who this might be right for
Thyroid Papillary CarcinomaContrast Enhanced Ultrasound
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 600
Not applicableUnknownNCT03889769
What this trial is testing

Evaluation of Accuracy of One-Step Nucleic Acid Amplification (OSNA) in Diagnosis of Lymph Node Metastases of Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid CancerLymph Node Metastases
University of Cagliari 50
Not applicableLooking for participantsNCT05766098
What this trial is testing

Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY

Who this might be right for
Papillary Thyroid Cancer
Istituto Auxologico Italiano 600
Post-approval studies (Phase 4)Not Yet RecruitingNCT07354698
What this trial is testing

Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery

Who this might be right for
Papillary Thyroid Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 114
Not applicableUnknownNCT02648399
What this trial is testing

Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma

Who this might be right for
Thyroid Papillary Carcinoma
Fujian Medical University 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Not applicableLooking for participantsNCT07302672
What this trial is testing

Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma
Ming-an Yu 108
Not applicableApproved For MarketingNCT03906331
What this trial is testing

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

Who this might be right for
Non Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+4 more
Eli Lilly and Company
Not applicableStudy completedNCT06592118
What this trial is testing

Clinical and Surgical Outcomes of Thyroid Carcinoma in Children and Adolescents

Who this might be right for
Pediatric and Adolescent Differentiated Thyroid CarcinomaSEER Database Analysis
Dezhou Hospital Qilu Hospital of Shandong University 3,068
Next Page